Mahmoud Allouache

646 total citations
21 papers, 371 citations indexed

About

Mahmoud Allouache is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Mahmoud Allouache has authored 21 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Mahmoud Allouache's work include Dialysis and Renal Disease Management (10 papers), Neurological and metabolic disorders (6 papers) and Vascular Procedures and Complications (4 papers). Mahmoud Allouache is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Neurological and metabolic disorders (6 papers) and Vascular Procedures and Complications (4 papers). Mahmoud Allouache collaborates with scholars based in France, United States and Norway. Mahmoud Allouache's co-authors include F. Martinez, H Beaufils, A. Laradi, Alain Mallet, Belkacem Issad, Alexandros Mallios, Benoît Boura, J Rottembourg, Alessandro Costanzo and William C. Jennings and has published in prestigious journals such as Journal of the American Society of Nephrology, American Journal of Kidney Diseases and Journal of Vascular Surgery.

In The Last Decade

Mahmoud Allouache

19 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahmoud Allouache France 11 206 100 94 75 75 21 371
Merit F. Gadallah United States 15 132 0.6× 85 0.8× 75 0.8× 92 1.2× 38 0.5× 16 416
Kelly Weigel United States 7 166 0.8× 17 0.2× 46 0.5× 196 2.6× 36 0.5× 11 505
L Sellars United Kingdom 13 267 1.3× 140 1.4× 153 1.6× 125 1.7× 35 0.5× 28 503
Covadonga Hevia Spain 12 282 1.4× 100 1.0× 69 0.7× 160 2.1× 20 0.3× 23 399
Ali Mirza Onder United States 13 168 0.8× 157 1.6× 97 1.0× 43 0.6× 34 0.5× 27 447
Joseph A. Coladonato United States 8 241 1.2× 94 0.9× 102 1.1× 32 0.4× 10 0.1× 10 340
Chiu‐Ching Huang Taiwan 12 178 0.9× 53 0.5× 87 0.9× 89 1.2× 49 0.7× 32 453
Johan Vestergaard Povlsen Denmark 11 353 1.7× 87 0.9× 57 0.6× 106 1.4× 49 0.7× 31 586
Ayşegül Zumrutdal Türkiye 10 154 0.7× 68 0.7× 76 0.8× 75 1.0× 17 0.2× 26 349
Francisco Coronel Spain 14 318 1.5× 74 0.7× 73 0.8× 116 1.5× 28 0.4× 60 548

Countries citing papers authored by Mahmoud Allouache

Since Specialization
Citations

This map shows the geographic impact of Mahmoud Allouache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud Allouache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud Allouache more than expected).

Fields of papers citing papers by Mahmoud Allouache

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmoud Allouache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud Allouache. The network helps show where Mahmoud Allouache may publish in the future.

Co-authorship network of co-authors of Mahmoud Allouache

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmoud Allouache. A scholar is included among the top collaborators of Mahmoud Allouache based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmoud Allouache. Mahmoud Allouache is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mallios, Alexandros, Mahmoud Allouache, Alessandro Costanzo, et al.. (2021). Comparison of surgical versus percutaneously created arteriovenous hemodialysis fistulas. Journal of Vascular Surgery. 74(1). 209–216. 26 indexed citations
2.
Mallios, Alexandros, et al.. (2021). Comparison of Surgical Versus Percutaneously Created Arteriovenous Hemodialysis Fistulas. Journal of Vascular Surgery. 73(3). 45–45. 2 indexed citations
3.
Mallios, Alexandros, et al.. (2020). Percutaneous arteriovenous dialysis fistula. Journal of Vascular Surgery. 71(4). 1395–1395. 9 indexed citations
4.
Mallios, Alexandros, P Bourquelot, Gilbert Franco, et al.. (2020). Midterm results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System, technical recommendations, and an algorithm for maintenance. Journal of Vascular Surgery. 72(6). 2097–2106. 40 indexed citations
5.
Mercadal, Lucile, Sophie Tézenas du Montcel, Michel B. Chonchol, et al.. (2018). Effects of L-Carnitine on Mineral Metabolism in the Multicentre, Randomized, Double Blind, Placebo-Controlled CARNIDIAL Trial. American Journal of Nephrology. 48(5). 349–356. 3 indexed citations
6.
Rottembourg, Jacques, et al.. (2015). Outcome and Follow-Up on CAPD. Contributions to nephrology. 89. 16–27.
7.
Rottembourg, J, et al.. (2015). Role of Acetate in Loss of Ultrafiltration during CAPD. Contributions to nephrology. 57. 197–206.
8.
Mercadal, Lucile, Mathieu Coudert, Anne Vassault, et al.. (2012). L-Carnitine Treatment in Incident Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 7(11). 1836–1842. 26 indexed citations
9.
Bollée, Guillaume, Benoît Guéry, Dominique Joly, et al.. (2008). Presentation and Outcome of Patients with Systemic Amyloidosis Undergoing Dialysis. Clinical Journal of the American Society of Nephrology. 3(2). 375–381. 41 indexed citations
10.
Laradi, A., Alain Mallet, H Beaufils, Mahmoud Allouache, & F. Martinez. (1998). HIV-associated nephropathy. Journal of the American Society of Nephrology. 9(12). 2327–2335. 83 indexed citations
11.
Issad, Belkacem, et al.. (1996). 213 Elderly Uremic Patients over 75 Years of Age Treated with Long Term Peritoneal Dialysis: A French Multicenter Study. Peritoneal Dialysis International. 16(1_suppl). 414–420. 33 indexed citations
12.
Issad, Belkacem, et al.. (1996). 213 Elderly Uremic Patients over 75 Years of age Treated with Long Term Peritoneal Dialysis: A French Multicenter Study. Peritoneal Dialysis International. 16(2_suppl). 414–420. 5 indexed citations
13.
Rottembourg, Jacques, et al.. (1995). [Treatment by continuous ambulatory peritoneal dialysis for chronic renal insufficiency in the diabetic].. PubMed. 16(1). 111–21. 1 indexed citations
14.
Issad, Belkacem, C. Mouquet, Mahmoud Allouache, et al.. (1994). Is overhydration in CAPD patients a contraindication to renal transplantation?. PubMed. 10. 68–72. 15 indexed citations
15.
Thillet, Joëlle, Claire Faucher, Belkacem Issad, et al.. (1993). Lipoprotein(a) in Patients Treated by Continuous Ambulatory Peritoneal Dialysis. American Journal of Kidney Diseases. 22(1). 226–232. 23 indexed citations
16.
Rottembourg, J, et al.. (1993). Insulin Prescription, Glycemic Control, and Diabetic Complications in Diabetics Treated by Continuous Ambulatory Peritoneal Dialysis. Peritoneal Dialysis International. 13(2_suppl). 232–235. 4 indexed citations
17.
Rottembourg, J, Belkacem Issad, Mahmoud Allouache, & C Jacobs. (1989). Recovery of renal function in patients treated by CAPD.. PubMed. 5. 63–6. 17 indexed citations
18.
Bardin, Thomas, B Faller, Christian Verger, et al.. (1989). Rheumatic syndromes and β2‐microglobulin amyloidosis in patients receiving long‐term peritoneal dialysis. Arthritis & Rheumatism. 32(6). 785–788. 19 indexed citations
19.
Rottembourg, Jacques, Belkacem Issad, Mahmoud Allouache, et al.. (1988). [Clinical aspects of continuous ambulatory peritoneal dialysis in diabetics].. PubMed. 9(5). 227–32. 3 indexed citations
20.
Rottembourg, J, et al.. (1988). [Prevention of peritonitis during continuous ambulatory peritoneal dialysis. Value of disconnectable systems].. PubMed. 17(26). 1349–53. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Merit F. Gadallah Breakdown of academic impact, for papers by Kelly Weigel Breakdown of academic impact, for papers by L Sellars Breakdown of academic impact, for papers by Covadonga Hevia Breakdown of academic impact, for papers by Ali Mirza Onder Breakdown of academic impact, for papers by Joseph A. Coladonato Breakdown of academic impact, for papers by Chiu‐Ching Huang Breakdown of academic impact, for papers by Johan Vestergaard Povlsen Breakdown of academic impact, for papers by Ayşegül Zumrutdal Breakdown of academic impact, for papers by Francisco Coronel
Rankless by CCL
2026